Hemogenyx Pharmaceuticals

Hemogenyx Pharmaceuticals The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases.

Hemogenyx Pharmaceuticals is a biopharmaceutical group developing new medicines and treatments to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceutical

s LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.

06/19/2024

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) CEO Dr Vladislav Sandler talked with Proactive about the company's recent operations update. In the...

04/25/2024

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) chair Marc Feldmann, in the company’s final results statement, described the year as a “period was a...

03/13/2024

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) Dr Vladislav Sandler joins Proactive's Stephen Gunnion after the pre-clinical stage biopharmaceutical...

🌟 Witness the cutting-edge innovation of as they revolutionize drug development!Their groundbreaking methods and techno...
06/20/2023

🌟 Witness the cutting-edge innovation of as they revolutionize drug development!Their groundbreaking methods and technologies are saving lives by creating new and effective medicines. Join the journey of scientific discovery and hope! 🚀

https://lnkd.in/eBCnyMdv

08/10/2022

One of America's Top Bone Marrow Transplant and Oncology Doctors Joins Hemogenyx Pharmaceuticals as Medical Director

Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, announces the appointment of Dr Koen van Besien as Medical Director.

07/13/2022

Address

1361 Amsterdam Avenue
New York, NY
10027

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+13477358380

Website

Alerts

Be the first to know and let us send you an email when Hemogenyx Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Hemogenyx Pharmaceuticals:

Shortcuts

Share

Category